The gripping and shocking story of three generations of the Sackler family and their roles in the stories of Valium and Oxycontin, by the prize-winning, bestselling author of Say Nothing.

The Sackler name adorns the walls of many storied institutions – Harvard; the Metropolitan Museum of Art; Oxford; the Louvre. They are one of the richest families in the world, known for their lavish donations in the arts and the sciences. The source of the family fortune was vague, however, until it emerged that the Sacklers were responsible for making and marketing Oxycontin, a blockbuster painkiller that was a catalyst for the opioid crisis-an international epidemic of drug addiction which has killed nearly half a million people.

In this masterpiece of narrative reporting and writing, Patrick Radden Keefe exhaustively documents the jaw-dropping and ferociously compelling reality. Empire of Pain is the story of a dynasty: a parable of 21st century greed.

Now in its third edition, Pharmacology in Clinical Practice has been updated to ensure it remains up-to-date and relevant.

Particular care has been taken to simplify and clarify difficult concepts by explaining the links between pharmacology and physiology by providing definitions of new concepts, and using plain language for ease of understanding. Fundamental concepts, such as pharmacodynamics and pharmacokinetics, are well covered in a matter that is accessible and clear. Individual chapters cover the various systems of the body.

Updates include:

• A colour plate to illustrate the links between pharmacology and physiology
• Additional information on side-effects, contra-indications and patient education for groups of drugs
• A guide on how to access this information, to assist with exam preparation and nursing practice
• An updated chapter on nursing management of drug preparations and treatment
• An updated chapter on clinical applications
• A chapter on the legal framework for dispensing and prescribing.

Human Biochemistry, Second Edition provides a comprehensive, pragmatic introduction to biochemistry as it relates to human development and disease. Here, Gerald Litwack, award-wining researcher and longtime teacher, discusses the biochemical aspects of organ systems and tissue, cells, proteins, enzymes, insulins and sugars, lipids, nucleic acids, amino acids, polypeptides, steroids, and vitamins and nutrition, among other topics. Fully updated to address recent advances, the new edition features fresh discussions on hypothalamic releasing hormones, DNA editing with CRISPR, new functions of cellular prions, plant-based diet and nutrition, and much more. Grounded in problem-driven learning, this new edition features clinical case studies, applications, chapter summaries, and review-based questions that translate basic biochemistry into clinical practice, thus empowering active clinicians, students and researchers.

Encyclopedia of Respiratory Medicine, Second Edition, Six Volume Set explores the key processes of lung diseases and their diagnosis and management. The book dissects the molecular and cellular biology, physiology and immunology that underpin normal lung function, along with the aberrations that occur in respiratory diseases, from common disorders such as asthma and COPD to rarer lung diseases such as cystic fibrosis, interstitial lung diseases and pulmonary hypertension. Written in at a time when the globe is in the grip of respiratory pandemic, lung disease has never been so prominent in the public and political conscious. This new edition will provide new researchers in respiratory medicine with a solid foundation in unfamiliar topics and will update more experienced researchers seeking to step outside their core areas of research to put their work into a broader context.

Radical SAM Enzymes, Volume 606, the latest release in the Methods in Enzymology series, highlights new advances in the field, with this new volume presenting interesting chapters on the Characterization of the glycyl radical enzyme choline trimethylamine-lyase and its radical S-adenosylmethionine activating enzyme, Diphathimide biosynthesis, Radical SAM glycyl radical activating enzymes, Radical SAM enzyme BioB in the biosynthesis of biotin, Biogenesis of the PQQ cofactor, Role of MoaAC in the biogenesis of the molybdenum cofactor, Biosynthesis of the nitrogenase cofactor, Bioinformatics of the radical SAM superfamily, The involvement of SAM radical enzymes in the biosynthesis of methanogenic coenzymes, methanopterin and coenzyme F420, and more.

Lung Epithelial Biology in the Pathogenesis of Pulmonary Disease provides a one-stop resource capturing developments in lung epithelial biology related to basic physiology, pathophysiology, and links to human disease. The book provides access to knowledge of molecular and cellular aspects of lung homeostasis and repair, including the molecular basis of lung epithelial intercellular communication and lung epithelial channels and transporters. Also included is coverage of lung epithelial biology as it relates to fluid balance, basic ion/fluid molecular processes, and human disease. Useful to physician and clinical scientists, the contents of this book compile the important and most current findings about the role of epithelial cells in lung disease. Medical and graduate students, postdoctoral and clinical fellows, as well as clinicians interested in the mechanistic basis for lung disease will benefit from the books examination of principles of lung epithelium functions in physiological condition.

"The Psychology of Illness: In Sickness and In Health" serves as a guide for therapists working with chronically ill patients. It weaves together theory, clinical experience, case examples, and up-to-date research. The book's flexible approach involves several modalities, including psychodynamic, cognitive-behavioral, pharmacological, and family treatments. This book teaches that therapists can help patients cope not only with the illness, but also with the complex relationships they will have with their physicians and the medical establishment.

Dr. Druss's unique book is divided into two sections. The first section, "Sickness," focuses on the subjective experience of being chronically ill. The second, "Health," is concerned with health and the quality of life. This book includes such topics as "healthy denial" and programs for staying healthy, such as exercise.

This volume is the third in a series of succinct, analytical reviews of advances in the psychiatric care of medically ill patients. Like the previous volumes, "Medical-Psychiatric Practice, Volume 3" is designed to continually update the busy clinician on research and practical developments in medical psychiatry.

Under the guidance of an eminent editorial advisory board, this volume addresses several specific clinical problems that require an integrated medical-psychiatric approach to their diagnosis and treatment. It includes an in-depth discussion of psychopharmacokinetics as well as an update on psychopharmacology in medically ill patients.

`General practitioners are in the front line where viral diseases are concerned, and they may sometimes need support in what is a rapidly developing field. The twenty-first century has seen a revolution in the speed and range of laboratory diagnosis as well as a new phase in viral immunisation and antiviral treatment. Advances in clinical medicine have led to new susceptibilities to viruses, and pandemic viral diseases as well as expanding travel to the developing world, have led to viral exposures that were rarely encountered in the past. This useful book is based on case vignettes that describe situations often seen in general practice. It is based on plentiful references to the current literature and brings the latest knowledge on laboratory diagnostics, infection control/public health measures and antiviral treatments to the attention of general practitioners and trainees in medical microbiology and public health medicine. It can also serve as a primer for postgraduate examinations in medicine. It can be read with interest and referred to with benefit.' Prepublication review by Dr Philip Mortimer MD (London) Written by Dr Brendan Crowley MSc MD DTM FRCPath FFPath(RCPI) Edited by Professor Anna Maria Geretti MD PhD FRCPath

This book examines evidence suggesting that psychiatric disorders may complicate medical illness, that personality may influence the onset and course of illness, and that psychosocial treatments may influence medical as well as psychiatric outcome. "Psychological Factors Affecting Medical Conditions" is a collection of articles that originally appeared in "Psychosomatics."

High-level commentary on various facets of the pharmaceutical industry from a key leader in the field This book clearly explains the value that the pharmaceutical industry offers to society which is often underreported against the more negative topic of high drug prices. It also offers an overview for drug discovery and development professionals, highlighting the challenges that such drug hunters should be aware of when developing new drugs. Case studies to illustrate topics like hepatitis C, mRNA vaccines, insulin, and price controls are included to aid in seamless reader comprehension. Written by John LaMattina, former president of Pfizer Global Research and Development and well-known speaker and writer for the pharma industry, sample topics covered and questions explored within the work include: Fiscal consequences of curing hepatitis C mRNA vaccines and the race for a cure Why the government does not deserve a piece of Biopharma's profits Paying for drugs whose ultimate value is unknown The impact of reduced revenues on R&D This book is a must-read for biopharmaceutical professionals and executives who wish to gain high-level insight into key challenges that must be first understood, then overcome, within the pharmaceutical industry.

The medical domain is home to many critical challenges that stand to be overcome with the use of data-driven clinical decision support systems (CDSS), and there is a growing set of examples of automated diagnosis, prognosis, drug design, and testing. However, the current state of AI in medicine has been summarized as "high on promise and relatively low on data and proof." If such problems can be addressed, a data-driven approach will be very important to the future of CDSSs as it simplifies the knowledge acquisition and maintenance process, a process that is time-consuming and requires considerable human effort. Diverse Perspectives and State-of-the-Art Approaches to the Utilization of Data-Driven Clinical Decision Support Systems critically reflects on the challenges that data-driven CDSSs must address to become mainstream healthcare systems rather than a small set of exemplars of what might be possible. It further identifies evidence-based, successful data-driven CDSSs. Covering topics such as automated planning, diagnostic systems, and explainable artificial intelligence, this premier reference source is an excellent resource for medical professionals, healthcare administrators, IT managers, pharmacists, students and faculty of higher education, librarians, researchers, and academicians.

Biotechnology in Healthcare presents up-to-date knowledge on the emerging field of biotechnology as applied to the healthcare industry. Biotechnology has revolutionized healthcare in the last two decades by developing and introducing novel diagnostics, therapeutics, and preventive measures; whether it is noncommunicable or communicable disease, primary or secondary care, or public health, it has shown its immense potential to provide a solution to the healthcare providers, physicians, and allied health care professionals. The second volume, Applications and Initiatives, contains 19 chapters focused on the applications of biotechnology related to public healthcare, hospital management, oncology, neurodegenerative and infectious diseases, regenerative medicine, IVF, clinical trials, precision food, FMGCs, PPCPs, pharmaceuticals, and smart technologies to monitor pandemic. Further, this volume also presents government initiatives and entrepreneurship challenges in healthcare biotechnology sector. This is a valuable resource for students, biotechnologists, bioinformaticians, clinicians, and members of biomedical and healthcare fields who need to understand more about the promising developments of the emerging field of biotechnology in healthcare.